• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质翻译后修饰在癌症特征调控中的作用

Protein post-translational modifications in the regulation of cancer hallmarks.

作者信息

Wang Haiying, Yang Liqian, Liu Minghui, Luo Jianyuan

机构信息

Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, Department of Biochemistry and Biophysics, School of Basic Medical Sciences, Peking University Health Science Center, 100191, Beijing, China.

Department of Medical Genetics, Center for Medical Genetics, Peking University Health Science Center, 100191, Beijing, China.

出版信息

Cancer Gene Ther. 2023 Apr;30(4):529-547. doi: 10.1038/s41417-022-00464-3. Epub 2022 Apr 7.

DOI:10.1038/s41417-022-00464-3
PMID:35393571
Abstract

Posttranslational modifications (PTMs) of proteins, the major mechanism of protein function regulation, play important roles in regulating a variety of cellular physiological and pathological processes. Although the classical PTMs, such as phosphorylation, acetylation, ubiquitination and methylation, have been well studied, the emergence of many new modifications, such as succinylation, hydroxybutyrylation, and lactylation, introduces a new layer to protein regulation, leaving much more to be explored and wide application prospects. In this review, we will provide a broad overview of the significant roles of PTMs in regulating human cancer hallmarks through selecting a diverse set of examples, and update the current advances in the therapeutic implications of these PTMs in human cancer.

摘要

蛋白质的翻译后修饰(PTMs)是蛋白质功能调控的主要机制,在调节多种细胞生理和病理过程中发挥着重要作用。尽管经典的翻译后修饰,如磷酸化、乙酰化、泛素化和甲基化,已经得到了深入研究,但许多新的修饰,如琥珀酰化、羟基丁酰化和乳酰化的出现,为蛋白质调控增添了新的层面,仍有许多有待探索之处,且具有广阔的应用前景。在本综述中,我们将通过选取一系列不同的例子,广泛概述翻译后修饰在调控人类癌症特征中的重要作用,并更新这些翻译后修饰在人类癌症治疗意义方面的当前进展。

相似文献

1
Protein post-translational modifications in the regulation of cancer hallmarks.蛋白质翻译后修饰在癌症特征调控中的作用
Cancer Gene Ther. 2023 Apr;30(4):529-547. doi: 10.1038/s41417-022-00464-3. Epub 2022 Apr 7.
2
Comparative Analysis of Post-Translational Modifications of Human Serum Albumin Derived from Human Plasma and Recombinant Sources in China.中国来源的人血浆来源和重组来源的人血清白蛋白的翻译后修饰的比较分析。
Discov Med. 2024 May;36(184):1054-1069. doi: 10.24976/Discov.Med.202436184.98.
3
Pathological implication of protein post-translational modifications in cancer.蛋白质翻译后修饰在癌症中的病理意义
Mol Aspects Med. 2022 Aug;86:101097. doi: 10.1016/j.mam.2022.101097. Epub 2022 Apr 7.
4
Advances in post-translational modifications of proteins and cancer immunotherapy.蛋白质翻译后修饰与癌症免疫治疗的新进展。
Front Immunol. 2023 Aug 22;14:1229397. doi: 10.3389/fimmu.2023.1229397. eCollection 2023.
5
[Advances in Post-translational Modifications and Endometriosis].[翻译后修饰与子宫内膜异位症的研究进展]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2020 Dec 30;42(6):810-814. doi: 10.3881/j.issn.1000-503X.11427.
6
Post-Translational Modifications of Extracellular Proteasome.细胞外蛋白酶体的翻译后修饰。
Molecules. 2020 Jul 31;25(15):3504. doi: 10.3390/molecules25153504.
7
The role of protein post-translational modifications in prostate cancer.蛋白质翻译后修饰在前列腺癌中的作用。
PeerJ. 2024 Aug 12;12:e17768. doi: 10.7717/peerj.17768. eCollection 2024.
8
A Text Mining and Machine Learning Protocol for Extracting Posttranslational Modifications of Proteins from PubMed: A Special Focus on Glycosylation, Acetylation, Methylation, Hydroxylation, and Ubiquitination.一种从 PubMed 中提取蛋白质翻译后修饰的文本挖掘和机器学习协议:特别关注糖基化、乙酰化、甲基化、羟化和泛素化。
Methods Mol Biol. 2022;2496:179-202. doi: 10.1007/978-1-0716-2305-3_10.
9
Protein post-translational modifications in auxin signaling.生长素信号转导中的蛋白质翻译后修饰。
J Genet Genomics. 2024 Mar;51(3):279-291. doi: 10.1016/j.jgg.2023.07.002. Epub 2023 Jul 12.
10
Post-translational modification of mitochondria as a novel mode of regulation.线粒体的翻译后修饰作为一种新的调控模式。
Exp Gerontol. 2014 Aug;56:202-20. doi: 10.1016/j.exger.2014.03.006. Epub 2014 Mar 12.

引用本文的文献

1
Effects of lactylation on the hallmarks of cancer (Review).乳酰化对癌症特征的影响(综述)
Oncol Lett. 2025 Aug 20;30(5):492. doi: 10.3892/ol.2025.15238. eCollection 2025 Nov.
2
From gut to proteomics: the impact of on post-translational modifications in colorectal cancer.从肠道到蛋白质组学:[具体因素]对结直肠癌翻译后修饰的影响。 (原文中“the impact of ”部分缺失具体内容)
Front Oncol. 2025 Aug 18;15:1599183. doi: 10.3389/fonc.2025.1599183. eCollection 2025.
3
MRPL12 K163 acetylation inhibits ccRCC via driving mitochondrial metabolic reprogramming.

本文引用的文献

1
Deubiquitinases: From mechanisms to their inhibition by small molecules.去泛素化酶:从机制到小分子抑制。
Mol Cell. 2022 Jan 6;82(1):15-29. doi: 10.1016/j.molcel.2021.10.027. Epub 2021 Nov 22.
2
Upregulation of α enolase (ENO1) crotonylation in colorectal cancer and its promoting effect on cancer cell metastasis.α烯醇化酶(ENO1)巴豆酰化在结直肠癌中的上调及其对癌细胞转移的促进作用。
Biochem Biophys Res Commun. 2021 Nov 12;578:77-83. doi: 10.1016/j.bbrc.2021.09.027. Epub 2021 Sep 16.
3
Global Insights Into Lysine Acylomes Reveal Crosstalk Between Lysine Acetylation and Succinylation in Streptomyces coelicolor Metabolic Pathways.
MRPL12 K163位点的乙酰化通过驱动线粒体代谢重编程抑制肾透明细胞癌。
Cell Death Dis. 2025 Aug 26;16(1):646. doi: 10.1038/s41419-025-07896-3.
4
Oxidative stress-induced ZEB1 acetylation drives a hybrid epithelial-mesenchymal phenotype and promotes lung metastasis in triple-negative breast cancer.氧化应激诱导的ZEB1乙酰化驱动混合上皮-间质表型并促进三阴性乳腺癌的肺转移。
Redox Biol. 2025 Aug 19;86:103834. doi: 10.1016/j.redox.2025.103834.
5
Yin Yang 1: Role in Leishmaniasis.阴阳1:在利什曼病中的作用
Cells. 2025 Jul 25;14(15):1149. doi: 10.3390/cells14151149.
6
Nonhistone lactylation: A hub for tumour metabolic reprogramming and epigenetic regulation.非组蛋白乳酰化:肿瘤代谢重编程和表观遗传调控的枢纽
J Transl Med. 2025 Aug 12;23(1):901. doi: 10.1186/s12967-025-06813-8.
7
KD_MultiSucc: incorporating multi-teacher knowledge distillation and word embeddings for cross-species prediction of protein succinylation sites.KD_MultiSucc:结合多教师知识蒸馏和词嵌入用于蛋白质琥珀酰化位点的跨物种预测
Biol Methods Protoc. 2025 May 28;10(1):bpaf041. doi: 10.1093/biomethods/bpaf041. eCollection 2025.
8
'Intelligent' proteins.“智能”蛋白质。
Cell Mol Life Sci. 2025 Jun 14;82(1):239. doi: 10.1007/s00018-025-05770-1.
9
Inferring kinase-phosphosite regulation from phosphoproteome-enriched cancer multi-omics datasets.从富含磷酸化蛋白质组的癌症多组学数据集中推断激酶-磷酸化位点调控。
Brief Bioinform. 2025 Mar 4;26(2). doi: 10.1093/bib/bbaf143.
10
Posttranslational Modification in Bone Homeostasis and Osteoporosis.骨稳态与骨质疏松中的翻译后修饰
MedComm (2020). 2025 Apr 1;6(4):e70159. doi: 10.1002/mco2.70159. eCollection 2025 Apr.
全球赖氨酸酰基组研究揭示了变铅青链霉菌代谢途径中赖氨酸乙酰化和琥珀酰化之间的串扰。
Mol Cell Proteomics. 2021;20:100148. doi: 10.1016/j.mcpro.2021.100148. Epub 2021 Sep 14.
4
STK39 promotes breast cancer invasion and metastasis by increasing SNAI1 activity upon phosphorylation.STK39 通过磷酸化增加 SNAI1 活性促进乳腺癌侵袭和转移。
Theranostics. 2021 Jun 11;11(16):7658-7670. doi: 10.7150/thno.62406. eCollection 2021.
5
SIRT7: a sentinel of genome stability.SIRT7:基因组稳定性的哨兵。
Open Biol. 2021 Jun;11(6):210047. doi: 10.1098/rsob.210047. Epub 2021 Jun 16.
6
Inflammation-Induced Tumorigenesis and Metastasis.炎症诱导的肿瘤发生和转移。
Int J Mol Sci. 2021 May 21;22(11):5421. doi: 10.3390/ijms22115421.
7
An unexpected role for p53 in regulating cancer cell-intrinsic PD-1 by acetylation.p53在通过乙酰化调节癌细胞内在程序性死亡受体1(PD-1)方面的意外作用。
Sci Adv. 2021 Mar 31;7(14). doi: 10.1126/sciadv.abf4148. Print 2021 Mar.
8
Function and Mechanism of Novel Histone Posttranslational Modifications in Health and Disease.新型组蛋白翻译后修饰在健康和疾病中的功能和机制。
Biomed Res Int. 2021 Mar 3;2021:6635225. doi: 10.1155/2021/6635225. eCollection 2021.
9
NAD Precursors, Mitochondria Targeting Compounds and ADP-Ribosylation Inhibitors in Treatment of Inflammatory Diseases and Cancer.NAD 前体、靶向线粒体的化合物和 ADP-核糖基化抑制剂在治疗炎症性疾病和癌症中的应用。
Curr Med Chem. 2021;28(41):8453-8479. doi: 10.2174/0929867328666210118152653.
10
PRMT5 and Tip60 Modify FOXP3 Function in Tumor Immunity.PRMT5和Tip60在肿瘤免疫中调节FOXP3功能。
Crit Rev Immunol. 2020;40(4):283-295. doi: 10.1615/CritRevImmunol.2020034789.